Mark Duncan Findlay1,2, Jesse Dawson3, David Alexander Dickie3, Kirsten P Forbes4, Deborah McGlynn3,2, Terry Quinn3, Patrick B Mark1,2. 1. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK; mark.findlay@nhs.net. 2. The Glasgow Renal & Transplant Unit, Queen Elizabeth University Hospital, Glasgow, UK; and. 3. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. 4. Department of Neuroradiology, Queen Elizabeth University Hospital, Glasgow, UK.
Abstract
BACKGROUND: The immediate and longer-term effects of hemodialysis on cerebral circulation, cerebral structure, and cognitive function are poorly understood. METHODS: In a prospective observational cohort study of 97 adults (median age 59 years) receiving chronic hemodialysis, we used transcranial Doppler ultrasound to measure cerebral arterial mean flow velocity (MFV) throughout dialysis. Using a well validated neuropsychological protocol, we assessed cognitive function during and off dialysis and after 12 months of treatment. We also used brain magnetic resonance imaging (MRI) to assess atrophy, white matter hyperintensities (WMHs), and diffusion parameters, and tested correlations between MFV, cognitive scores, and changes on MRI. RESULTS: MFV declined significantly during dialysis, correlating with ultrafiltrate volumes. Percentage of decline in MFV correlated with intradialytic decline in cognitive function, including global function, executive function, and verbal fluency. At follow-up, 73 patients were available for repeat testing, 34 of whom underwent repeat MRI. In a subgroup of patients followed for 12 months of continued dialysis, percentage of decline in MFV correlated significantly with lower global and executive function and with progression of WMH burden (a marker of small vessel disease). Twelve of 15 patients who received renal transplants during follow-up had both early and follow-up off-dialysis assessments. After transplant, patients' memory (on a delayed recall test) improved significantly; increased fractional anisotropy of white matter (a measure of cerebral diffusion) in these patients correlated with improving executive function. CONCLUSIONS: Patients undergoing hemodialysis experience transient decline in cerebral blood flow, correlating with intradialytic cognitive dysfunction. Progressive cerebrovascular disease occurred in those continuing dialysis, but not in transplanted patients. Cognitive function and cerebral diffusion improved after transplant.
BACKGROUND: The immediate and longer-term effects of hemodialysis on cerebral circulation, cerebral structure, and cognitive function are poorly understood. METHODS: In a prospective observational cohort study of 97 adults (median age 59 years) receiving chronic hemodialysis, we used transcranial Doppler ultrasound to measure cerebral arterial mean flow velocity (MFV) throughout dialysis. Using a well validated neuropsychological protocol, we assessed cognitive function during and off dialysis and after 12 months of treatment. We also used brain magnetic resonance imaging (MRI) to assess atrophy, white matter hyperintensities (WMHs), and diffusion parameters, and tested correlations between MFV, cognitive scores, and changes on MRI. RESULTS:MFV declined significantly during dialysis, correlating with ultrafiltrate volumes. Percentage of decline in MFV correlated with intradialytic decline in cognitive function, including global function, executive function, and verbal fluency. At follow-up, 73 patients were available for repeat testing, 34 of whom underwent repeat MRI. In a subgroup of patients followed for 12 months of continued dialysis, percentage of decline in MFV correlated significantly with lower global and executive function and with progression of WMH burden (a marker of small vessel disease). Twelve of 15 patients who received renal transplants during follow-up had both early and follow-up off-dialysis assessments. After transplant, patients' memory (on a delayed recall test) improved significantly; increased fractional anisotropy of white matter (a measure of cerebral diffusion) in these patients correlated with improving executive function. CONCLUSIONS:Patients undergoing hemodialysis experience transient decline in cerebral blood flow, correlating with intradialytic cognitive dysfunction. Progressive cerebrovascular disease occurred in those continuing dialysis, but not in transplanted patients. Cognitive function and cerebral diffusion improved after transplant.
Authors: Mark J Sarnak; Hocine Tighiouart; Tammy M Scott; Kristina V Lou; Eric P Sorensen; Lena M Giang; David A Drew; Kamran Shaffi; James A Strom; Ajay K Singh; Daniel E Weiner Journal: Neurology Date: 2013-01-09 Impact factor: 9.910
Authors: Manjula Kurella Tamura; Eric Vittinghoff; Chi-Yuan Hsu; Karman Tam; Stephen L Seliger; Stephen Sozio; Michael Fischer; Jing Chen; Eva Lustigova; Louise Strauss; Rajat Deo; Alan S Go; Kristine Yaffe Journal: Kidney Int Date: 2017-01-27 Impact factor: 10.612
Authors: Manjula Kurella Tamura; Mark L Unruh; Allen R Nissenson; Brett Larive; Paul W Eggers; Jennifer Gassman; Ravindra L Mehta; Alan S Kliger; John B Stokes Journal: Am J Kidney Dis Date: 2012-11-11 Impact factor: 8.860
Authors: Konstadina Griva; Jan Stygall; Matthew Hankins; Andrew Davenport; Michael Harrison; Stanton P Newman Journal: Am J Kidney Dis Date: 2010-08-25 Impact factor: 8.860
Authors: Mark Findlay; Rachael MacIsaac; Mary Joan MacLeod; Wendy Metcalfe; Jamie P Traynor; Jesse Dawson; Patrick B Mark Journal: Nephrol Dial Transplant Date: 2018-09-01 Impact factor: 5.992
Authors: Joanna M Wardlaw; Eric E Smith; Geert J Biessels; Charlotte Cordonnier; Franz Fazekas; Richard Frayne; Richard I Lindley; John T O'Brien; Frederik Barkhof; Oscar R Benavente; Sandra E Black; Carol Brayne; Monique Breteler; Hugues Chabriat; Charles Decarli; Frank-Erik de Leeuw; Fergus Doubal; Marco Duering; Nick C Fox; Steven Greenberg; Vladimir Hachinski; Ingo Kilimann; Vincent Mok; Robert van Oostenbrugge; Leonardo Pantoni; Oliver Speck; Blossom C M Stephan; Stefan Teipel; Anand Viswanathan; David Werring; Christopher Chen; Colin Smith; Mark van Buchem; Bo Norrving; Philip B Gorelick; Martin Dichgans Journal: Lancet Neurol Date: 2013-08 Impact factor: 44.182
Authors: Rebecca J Lepping; Robert N Montgomery; Palash Sharma; Jonathan D Mahnken; Eric D Vidoni; In-Young Choi; Mark J Sarnak; William M Brooks; Jeffrey M Burns; Aditi Gupta Journal: J Am Soc Nephrol Date: 2020-10-16 Impact factor: 10.121